1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Investigator-Initiated Studies Program is a grant from Pfizer Inc. that funds independent investigator-sponsored research advancing medical and scientific knowledge about Pfizer therapies and disease areas.
The program supports pre-clinical and clinical studies involving Pfizer assets such as commercial drugs, investigational compounds, and pure substances, as well as general research on disease states including health services research, registry development, epidemiology, and outcomes research unrelated to Pfizer products.
Eligible applicants include researchers at accredited medical schools, research institutions, and academic centers worldwide who submit through their institution. Pfizer operates batched application windows throughout the year. Award amounts vary depending on the scope and therapeutic area of the proposed study, typically ranging up to several hundred thousand dollars.
Get alerted about grants like this
Save a search for “Pfizer Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Investigator Sponsored Research | Pfizer Investigator Sponsored Research Investigator Sponsored Research IMPORTANT: Pfizer has implemented application windows for unsolicited requests. Please click here to view the Application and Batched Review Cycles. Pfizer supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies.
An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. This global program is open to all researchers who are interested in conducting their own research.
This grant type is used as support for pre-clinical and clinical studies (including interventional and non-interventional), that involve a Pfizer asset (e.g., commercial drug, investigational drug, pure compound*). *Pfizer has an extensive pure substance library that encompasses our publicly known compounds.
Pfizer also supports general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset. This grant type is used to support research that does not include the study of a Pfizer asset, including health services research unrelated to a Pfizer asset, registry development and/or queries unrelated to a Pfizer asset, and outcomes research unrelated to a Pfizer asset.
This includes observational studies, such as epidemiology studies and certain outcomes research studies where the primary focus is the scientific understanding of disease as well as other types of independent research on disease states. Follow this link if you would like to view the Research Grant application prior to submission If you have any additional questions please email us at ExternalResearch& [email protected] .
Oncology Areas of Interest Rare Disease Areas of Interest Vaccines and Antivirals Areas of Interest Inflammation and Immunology Areas of Interest Internal Medicine Areas of Interest Anti-Infectives Areas of Interest Competitive Grant Program Learn about our Competitive Grant Program and view open RFPs Submit new or view existing applications through our Grant System
Based on current listing details, eligibility includes: U. S. medical schools and research institutions; applications must be submitted by an institution such as Morehouse School of Medicine, not individuals. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Typically up to several hundred thousand dollars depending on scope and area Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.